Stat5 is a prognostic marker for ER-positive breast cancer

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷 / 2期
关键词：
D O I：
10.1038/ncponc0701
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：66 / 66
相关论文
共 50 条
  • [31] Stat5 in breast cancer: potential oncogenic activity coincides with positive prognosis for the disease
    Barash, Itamar
    CARCINOGENESIS, 2012, 33 (12) : 2320 - 2325
  • [32] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Alomran, Reem
    White, Michelle
    Bruce, Melissa
    Bressel, Mathias
    Roache, Susan
    Karroum, Lama
    Hanna, Gerard G.
    Siva, Shankar
    Goel, Shom
    David, Steven
    BMC CANCER, 2021, 21 (01)
  • [33] Frequency and Significance of Basal Phenotype in ER-positive Breast Cancer
    Meyer, Anne-Sophie
    Kriegsmann, Mark
    Waldburger, Nina
    Jung, Audrey
    Behrens, Sabine
    Chang-Claude, Jenny
    Sinn, Hans-Peter
    MODERN PATHOLOGY, 2018, 31 : 91 - 91
  • [34] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [35] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    Breast Cancer Research, 7
  • [36] Reciprocal Effects of STAT5 and STAT3 in Breast Cancer
    Walker, Sarah R.
    Nelson, Erik A.
    Zou, Lihua
    Chaudhury, Mousumi
    Signoretti, Sabina
    Richardson, Andrea
    Frank, David A.
    MOLECULAR CANCER RESEARCH, 2009, 7 (06) : 966 - 976
  • [37] The Molecular Anatomy of Breast Cancer Stroma; Independent Prognostic Role in ER-Positive and ER-Negative Cancers.
    Bianchini, G.
    Alvarez, R. H.
    Qi, Y.
    Hatzis, C.
    Iwamoto, T.
    Shiang, C.
    Coutant, C.
    Hortobagyi, G. N.
    Symmans, W. F.
    Pusztai, L.
    CANCER RESEARCH, 2009, 69 (24) : 507S - 507S
  • [38] Marker assessments in ER-positive breast cancers: old markers, new applications?
    Li, Joshua J. X.
    Tse, Gary M.
    HISTOPATHOLOGY, 2023, 82 (02) : 218 - 231
  • [39] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Reem Alomran
    Michelle White
    Melissa Bruce
    Mathias Bressel
    Susan Roache
    Lama Karroum
    Gerard G. Hanna
    Shankar Siva
    Shom Goel
    Steven David
    BMC Cancer, 21
  • [40] Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma
    Klupp, Fee
    Diers, Johannes
    Kahlert, Christoph
    Neumann, Lena
    Halama, Niels
    Franz, Clemens
    Schmidt, Thomas
    Lasitschka, Felix
    Warth, Arne
    Weitz, Juergen
    Koch, Moritz
    Schneider, Martin
    Ulrich, Alexis
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S1548 - S1555
12345